https://pioneerinstitute.org/wp-content/uploads/Screenshot-2024-02-28-at-1.19.36-PM.png 674 1196 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2024-02-29 09:01:142024-02-29 11:20:48Boston Children’s, MGH Among Massachusetts Hospitals with Highest Relative Commercial Prices
Pioneer Institute's new tool, the Massachusetts Hospital Relative Price Tracker, displays relative price and facilitates relative price comparisons among hospitals. The average price among all hospitals will have a relative price of 1.0. A relative price of 1.5 means that a hospital charges 50 percent higher than the average of all Massachusetts hospitals. Similarly, a relative price of 0.84 means that a hospital’s prices are 16 percent below average. Relative price data is collected and reported by the Commonwealth’s Center for Health Information and Analysis (CHIA) and is an aggregate measure used to evaluate price variations among different hospitals. It is recalculated annually based on data collected from commercial payers and includes information on private commercial insurance and commercially managed public insurance products such as Medicare Advantage and Medicaid Managed Organizations/Accountable Care Partnership Plans.
https://pioneerinstitute.org/wp-content/uploads/Blog-Binoy-drugs-middlemen-02202024.png 1400 1400 Gauri Binoy https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Gauri Binoy2024-02-20 09:38:102024-02-20 09:38:10Middlemen Pushing Up Retail Costs of Drugs
The reality is that non-price factors, including several players, are causing net prices to decline and retail prices to increase. Those players include employers, health plans, and pharmacy benefit managers (PBMs), all of whom have continuously circumvented the system through loopholes and complicated systems of reimbursement that tend to hurt patients
https://pioneerinstitute.org/wp-content/uploads/Telehealth-Report-012320243-1.png 1400 1400 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2024-01-23 10:10:132024-01-23 10:10:13Telehealth Progress Slowed in 2023
A new report by Cicero Institute, Pioneer Institute, and Reason Foundation reveals worrying stagnation in state-level telehealth expansion efforts in 2023, with only a few exceptions. Progress made during the pandemic is being lost even as provider shortages worsen, raising concerns about patients’ access to care.
https://pioneerinstitute.org/wp-content/uploads/Blog-drug-prices-RD-Smith-012220242.png 1400 1400 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2024-01-22 10:09:202024-01-22 10:09:20‘High’ U.S. Drug Prices Mask Freeloading by Other Nations
The drug company’s choice is to walk away from millions in revenue from a given country and deny their people a lifesaving drug, or swallow hard and accept an unfair price that is nowhere near the drug’s value. For the sake of shareholders and patients, drug companies typically accept the unfair price and devote the revenue to offsetting their previous investments. In short, other nations are freeloading off of American R&D.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-183-Drug-Discount-01092024-.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2024-01-09 13:30:532024-01-09 13:30:53Drug Discount Distortions: How Middlemen Increase Costs and Reduce Access
Joe Selvaggi talks with Drs. Bill Smith and Robert Popovian about how the complex system of rebates from drug companies to insurance firms serve to increase costs and reduce access for patients.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-work-force.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-05-15 09:00:202023-05-15 15:38:49Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients
A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-Direct-Dispense.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-04-18 11:25:122023-05-04 16:27:06Out-of-Pocket Pirates: Spotlight on Accumulator & Maximizer Programs
A new white paper, "Out-of-Pocket Pirates: Pharmacy Benefit Managers (PBMs) and the Confiscation of Copayment Assistance Programs," examines how the way these programs are implemented is having negative impacts on patients living with serious diseases.
https://pioneerinstitute.org/wp-content/uploads/Screenshot-2023-02-15-at-8.58.00-AM.png 780 645 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-02-15 09:00:162023-05-15 15:40:40As COVID-19 Emergencies Ease, Some Progress on Telehealth Rules
A new report from Reason Foundation, Cicero Institute and Pioneer Institute rates every state’s telehealth policy for patient access and ease of providing virtual care. The report highlights telehealth policy best practices for states.
https://pioneerinstitute.org/wp-content/uploads/Pioneer-Institute-Statement-on-Question-1-1.png 512 1000 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-01-11 07:43:522023-01-11 07:44:28First-of-Its-Kind Interactive Mapping Tool Reveals Extent of For-Profit Entities Benefitting from the 340B Drug Pricing Program
Today, Pioneer Institute released a first-of-its-kind, 50-state mapping tool and database highlighting the troubling way in which hospitals and covered entities leverage unlimited pharmacy contracts under the 340B Drug Pricing Program.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-2023-01-10T094014.585.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2023-01-10 09:47:152023-01-24 13:39:01Shopping Hospital Value: Price Transparency Mandate Brings Market Forces to Medicine
Hubwonk host Joe Selvaggi talks with Pioneer Institute's senior healthcare fellow Barbara Anthony about her recently released paper, Massachusetts Hospitals: Uneven Compliance with New Federal Price Transparency Law, and how price transparency can empower consumers to shop for better value and encourage hospitals to offer more competitive costs.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-11.-Employees-of-the-Public-Sector-11.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-11-17 08:15:532022-12-01 10:03:26Survey Finds Spotty Compliance Among Hospitals with Federal Price Transparency Law
A 2019 federal law requires hospitals to make prices for 300 shoppable services available online in a “consumer-friendly format,” but a Pioneer Institute survey of 19 hospitals finds that information on discounted cash prices—the price most likely to be charged to consumers paying out of pocket—was unavailable at seven of those hospitals.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-99.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-11-08 09:44:342022-11-08 09:54:00Right To Save: Paying Healthcare Consumers To Shop For Value
This week on Hubwonk, host Joe Selvaggi talks with healthcare policy expert Josh Archambault about the findings from his Cicero Institute report, The Right to Save: The Next Generation of Price Transparency. He outlines how to incentivize healthcare consumers to utilize price information to reduce out-of-pocket costs, and lower healthcare costs for everyone.
https://pioneerinstitute.org/wp-content/uploads/drug_cost.png 512 1000 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2022-11-02 12:50:442022-11-02 12:54:47Is CHIA’s Drug Cost Data Reliable?
Earlier this year, the Center for Health Information and Analysis (CHIA) released its Annual Report on the Performance of the Massachusetts Health Care System for 2020. The Massachusetts Legislature relies on CHIA data when considering bills to regulate drug costs and prices. The advocacy group Health Care for All reported that CHIA data showed prescription drug spending grew by 7.7 percent in 2020, more than twice the benchmark - but the most reliable data on prescription drugs indicates that spending in 2020 was essentially flat.
https://pioneerinstitute.org/wp-content/uploads/Untitled-design-2022-09-16T095137.929.png 512 1000 Gauri Binoy https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Gauri Binoy2022-09-16 09:49:442022-09-16 09:52:05Is this PBM tactic blocking healthcare access?
Utilization Management (UM) was originally a strategy designed to improve the safety, quality, and cost-effectiveness of physician prescribing. However, UM has grown exponentially over the last decade, becoming more a tactic for Pharmacy Benefit Managers (PBMs) to manage costs to benefit their bottom line.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-86.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-08-09 10:36:292022-08-09 11:09:07Drug Price Control: Bad Medicine for Healthcare and Region
Hubwonk host Joe Selvaggi talks with Dr. Bill Smith, Director of Pioneer Institute’s Life Sciences Initiative, about the impact of the Inflation Reduction Act on long-term health costs. They discuss the bill's unintended consequences, potential effect on the region’s vibrant pharmaceutical research and development sector, and what citizens can do about it.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-11.-Employees-of-the-Public-Sector-5.png 512 1024 Gauri Binoy https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Gauri Binoy2022-08-08 15:26:072022-08-08 15:36:37The Realities Behind US Healthcare Spending
Healthcare policy is an all-encompassing term. It plays a role in every individual’s life; how it is curated, developed, and maintained has a significant long-term impact on the quality of life of any given community. It is critical that policymakers consistently adapt and amend healthcare policies in the ever-changing global pricing and affordability environment while providing funding support for optimal quality of care.
https://pioneerinstitute.org/wp-content/uploads/unnamed-7.jpg 185 512 Etelson Alcius https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Etelson Alcius2022-07-05 13:04:592022-07-05 13:04:59Healthcare dominates the job market.
Healthcare and social assistance are among the most important…
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-80.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-07-05 10:39:572022-07-05 12:35:45Drug Cost Disruption: Direct Generic Access Can Save Consumers Billions
Hubwonk host Joe Selvaggi talks with Dr. Hussain Lalani about his recently published research on the potential for more than $3 billion in savings were Medicare to use Mark Cuban’s new direct-to-consumer drug company to purchase generics.
https://pioneerinstitute.org/wp-content/uploads/Blog03-CoverImage-1.jpg 800 1600 Joseph Staruski https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Joseph Staruski2022-06-03 16:52:072022-06-03 17:01:10Healthcare Employs More on Cape Cod Than Any Other Sector
Despite being a major tourist destination, the largest employment sector on Cape Cod is not related to tourism: it is healthcare!
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template.jpg 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-05-17 10:29:402022-05-17 13:13:13Doctors With Borders: Curing Shortages With International Lifeline
This week on Hubwonk, host Joe Selvaggi talks with Cicero Institute’s Jonathan Wolfson about the growing doctor shortage and the potential to alleviate the crisis by tapping the global supply of well-trained physicians eager to find safety and freedom in the US.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-72.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-04-12 09:55:002022-04-12 10:43:34Pharmacy Benefit Profiteers: Distortions and Costs of Half-Trillion Dollar Drug Middlemen
Hubwonk Host Joe Selvaggi talks with ALVA10 Chief Executive Hannah Mamuszka and Dr. Blake Long about the perverse incentives imposed by Pharmacy Benefit Managers adding nearly $500 billion to U.S. drug costs.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-70.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-03-29 10:24:462022-03-29 10:24:46Exploiting Charity Drugs: Hospital Program Earns Billions But Forgets Mission
Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Dr. Bill Smith about his recently released paper entitled, "340B Drug Discounts, An Increasingly Dysfunctional Federal Program," which analyzes the evolution of a well-intentioned program to offer discounted drugs to the uninsured from a benefit that had helped charitable hospitals to one that has exploded to generate billions in profits while serving fewer uninsured.
https://pioneerinstitute.org/wp-content/uploads/340-web-post.png 900 1600 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-03-22 05:41:312022-03-25 14:38:00Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes
Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-67.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-03-08 10:49:512022-03-08 10:49:51Successful Aging Support: Reimagining Effective and Affordable Long-Term Care Solutions
Hubwonk host Joe Selvaggi talks with Brookings Institution Senior Fellow and healthcare policy expert Stuart Butler about the challenge of building long-term care systems and institutions that will support Americans as they age, without depleting assets and bankrupting the social safety net.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-66.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-03-01 11:31:452022-03-01 11:31:45Pandemic Dead Reckoning: Unseen Casualties of Public Health Interventions
Hubwonk host Host Joe Selvaggi talks with Pioneer Institute’s Senior Fellow Dr. Bill Smith about new evidence that during the past two years of the pandemic, there were as many unseen excess deaths from non-Covid-related diseases as seen from Covid. They discuss the need for public health leaders to pivot their messaging to address this hidden mortality.
https://pioneerinstitute.org/wp-content/uploads/Untitled-design1.png 512 1024 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2022-02-24 14:33:392022-02-24 14:33:39Why the jump in non-COVID deaths?
The Wall Street Journal echoes our warning about the rise of non-COVID-related deaths.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-65.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-02-22 10:14:022022-02-22 10:27:28Olympic-Scale Doctor Shortage: Tapping International Talent
Host Joe Selvaggi talks with Pioneer Institute's Senior Healthcare Policy Fellow Josh Archambault about the shortage of doctors in the U.S. and the potential for licensing reform to attract medical expertise from around the world to reduce future healthcare shortages and provide incentives for immigrating professionals to work in underserved communities.
https://pioneerinstitute.org/wp-content/uploads/Copy-of-telehealth-post-2-1.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-01-24 17:59:102022-01-24 17:59:10How did COVID impact Massachusetts’ long-term care facilities?
Pioneer Institute has filed a Public Records Act request related to COVID's impact on Massachusetts’ long-term care facilities because the Institute believes this is a matter of obvious importance, both on principle (the public has a right to know the facts), and for purposes of evaluating – and where possible improving – public policy.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-60.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-01-18 10:33:162022-01-24 17:09:10Massachusetts Telehealth Report Card: Are We Embracing Disruption for Better Quality of Care?
Hubwonk host Joe Selvaggi talks with Pioneer Senior Fellow in Healthcare Josh Archambault about his newest research paper, produced with the Cicero Institute and the Reason Foundation, on states' success in implementing telehealth to improve healthcare outcomes. They discuss how Massachusetts has used remote medicine to better reach patients and serve their needs.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-59.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2022-01-11 11:01:192022-11-22 09:06:13Am I Contagious? Divining Covid’s Community Conundrum
Hubwonk host Joe Selvaggi talks with Alva10 CEO and precision medicine expert Hannah Mamuszka about which tests are best for determining who is contagious and the implications for the CDC’s new isolation recommendations.